1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > CNS Drug News 02 FEBRUARY 2015

CNS Drug News 02 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Branded Antidepressants Market Has High Potential Despite Current Contraction
Industry Brief - AgeneBio Receives Grant For New Approach To Delaying Onset Of Alzheimer's Dementia
Industry Trend Analysis - Supreme Court Ruling Will Boost Teva's Copaxone Revenues
Industry Brief - Reata Enrols First Patient In Study Of RTA 408 For FA
Industry Trend Analysis - J&J's Three-Month Antipsychotic Will Be A Growth Driver
Industry Trend Analysis - Europe Opening Up To Adult ADHD
Industry Brief - Richter/Actavis Report Positive Phase III Results For Cariprazine
Industry Brief - BDSI Acquires North American Marketing Authorisations For Onsolis From Meda
Industry Trend Analysis - Zohydro ER's Abuse-Deterrent Label Delay Will Benefit Purdue
Industry Brief - Purdue's Abuse-Deterrent Hysingla ER Available In US
Industry Brief - Antares' Sumatriptan ANDA Receives CRL
Industry Brief - Premier Files Initial FDA Submission For Fibromyalgia Treatment
Industry Trend Analysis - Mounting Patent Challenges Will Determine Supernus' Financial Rewards
Industry Brief - UCB's Brivaracetam Applications Accepted For Review By FDA/EMA
Industry Brief - Exalief Soon To Be Available In Russia
Industry Brief - Impax Receives US Lamotrigine Approval
Industry Brief - Supernus Files Oxcarbazepine Patent Lawsuit Against TWi
Industry Brief - Alexza Initiates Phase IIa Study Of AZ-002 In Epilepsy Patients
Industry Brief - Vyvanse Becomes First FDA-Approved Treatment For Moderate-To-Severe BED In Adults
Industry Brief - Helsinn Grants Stendhal Exclusive Rights To NEPA In Multiple Countries Of Latin America
Industry Brief - PsychoGenics Achieves Further Milestone In Sunovion Collaboration
Industry Trend Analysis - Further Double-Digit Revenue Growth And Increased EPS For Biogen Idec In 2015
Industry Brief - Otsuka Opens Office In Australia

Table Of Contents

CNS Drug News 02 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.